FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:2193-2195 May 20, 2004 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Bristow, M. R. Related Article by Kadish, A. PubMed Citation

The left ventricle strives valiantly with each cardiac cycle to maximize contractility and provide protection against lethal ventricular arrhythmias. Heart failure can make this coordination difficult. Heart-rhythm and heart-failure specialists are increasingly working together to restore nature's performance and lifesaving features to the failing left ventricle. Our jobs are becoming progressively more entwined as we evaluate treatments involving pacemakers and implantable cardioverter–defibrillators (ICDs) in an effort to improve the quality of life and reduce the risk of complications and death among patients with left ventricular systolic dysfunction.

Several factors contribute to this new collaboration. First, heart-rhythm specialists acknowledge the dramatic . . . [Full Text of this Article]

Source Information

From the Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis.

This article has been cited by other articles:

• Cleland, J. G.F., Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., Tavazzi, L., on behalf of The CARE-HF Study Investigators, (2006). Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 27: 1928-1932 [Abstract] [Full Text]  
• Calvert, M. J., Freemantle, N., Yao, G., Cleland, J. G.F., Billingham, L., Daubert, J.-C., Bryan, S., on behalf of the CARE-HF Investigators, (2005). Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J 26: 2681-2688 [Abstract] [Full Text]  
• Cleland, J. G.F., Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., Tavazzi, L., the Cardiac Resynchronization -- Heart Failure (CA, (2005). The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. NEJM 352: 1539-1549 [Abstract] [Full Text]  
• (2004). Cardiac Resynchronization Therapy Faces the Morbidity-Mortality Test. Journal Watch Cardiology 2004: 6-6 [Full Text]  
• (2004). Cardiac Resynchronization Therapy Faces the Morbidity-Mortality Test. Journal Watch Cardiology 2004: 1-1 [Full Text]  
• (2004). Device Therapy Improves Outcomes in Heart-Failure Patients. JWatch General 2004: 1-1 [Full Text]